Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award

ATLANTA, June 7, 2011 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, announced today that its founder and CEO, Jay Yadav, M.D., is a finalist for the 25th annual 2011 Business Person of the Year Awards in the Experienced Entrepreneur category. The awards are sponsored by the Metro Atlanta Chamber and the Atlanta Business Chronicle and will be presented at a luncheon on Wednesday, June 15 at the Loews Hotel in Atlanta.

In its 25th year, the Business Person of the Year Awards honor outstanding small business professionals from the metro Atlanta area. Dr. Yadav is a finalist in the "Experienced Entrepreneur" category, which recognizes achievement by an entrepreneur who has owned a business for at least five years and has demonstrated exemplary business achievement, customer growth, community leadership, industry influence and entrepreneurial success in the past year. The award also acknowledges a business owner who has earned public recognition and serves as a mentor for other entrepreneurs.

Dr. Yadav, an interventional cardiologist, founded CardioMEMS in 2000 to develop new devices for the treatment of chronic cardiovascular diseases such as heart failure. Dr. Yadav's most recent success is the Champion Heart Failure Monitoring System, the first permanently implantable, wireless, battery-free device that provides crucial cardiac information from home for patients suffering from heart failure. In 2010, CardioMEMS completed its clinical trial for the Champion System, demonstrating a 38% reduction in heart failure related hospitalizations.

More information on the 2011 Business Person of the Year Awards and the luncheon on June 15 can be found at www.metroatlantachamber.com.

About CardioMEMS, Inc.

CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure, and hypertension. CardioMEMS miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data, which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. Using radiofrequency (RF) energy, the sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician. CardioMEMS developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about CardioMEMS is located at www.cardiomems.com.

Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

CardioMEMS and the CardioMEMS logo are registered trademarks of CardioMEMS, Inc. Champion is a trademark of CardioMEMS, Inc.

Caution: The Champion Heart Failure Monitoring system is an investigational device limited by federal law to investigational use.

SOURCE CardioMEMS, Inc.